Accent Microcell

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0Q5D01013
  • NSEID: ACCENTMIC
  • BSEID:
INR
674.25
3.9 (0.58%)
BSENSE

Sep 24, 03:30 PM

BSE+NSE Vol: 94500

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 31.92% vs 7.77% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 35.27% vs 6.17% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 56.32% vs -69.85% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 32.65% vs 9.60% in Mar 2025

Compare Profit and Loss Results of Accent Microcell
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
349.00
488.00
-139.00
-28.48%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
349.00
488.00
-139.00
-28.48%
Expenditure (Ex Depriciation)
Stock Adjustments
-3.00
-8.00
5.00
62.50%
Raw Materials Consumed
219.00
249.00
-30.00
-12.05%
Power & Fuel Cost
21.00
25.00
-4.00
-16.00%
Employee Cost
18.00
60.00
-42.00
-70.00%
Operating Expenses
12.00
71.00
-59.00
-83.10%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
15.00
6.00
9.00
150.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
11.00
-9.00
-81.82%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
292.00
427.00
-135.00
-31.62%
Operating Profit (PBDIT) excl Other Income
56.00
61.00
-5.00
-8.20%
Other Income
6.00
14.00
-8.00
-57.14%
Operating Profit (PBDIT)
63.00
75.00
-12.00
-16.00%
Interest
0.00
5.00
-5.00
-100.00%
Profit before Depriciation and Tax
62.00
70.00
-8.00
-11.43%
Depreciation
4.00
16.00
-12.00
-75.00%
Profit Before Taxation & Exceptional Items
58.00
54.00
4.00
7.41%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
58.00
54.00
4.00
7.41%
Provision for Tax
14.00
12.00
2.00
16.67%
Profit After Tax
43.00
41.00
2.00
4.88%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
96.00
274.00
-178.00
-64.96%
Profit Available for appropriations
140.00
315.00
-175.00
-55.56%
Appropriations
140.00
315.00
-175.00
-55.56%
Equity Dividend (%)
10%
35%
-25.00
Earnings Per Share
18.65
67.39
-48.74
-72.33%
Profit And Loss - Net Sales
Net Sales 349.03 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 31.92% vs 7.77% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 56.69 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 35.27% vs 6.17% in Mar 2025

Profit And Loss - Interest
Interest 0.54 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 56.32% vs -69.85% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 43.86 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 32.65% vs 9.60% in Mar 2025

Footer loading